SecBot SecBot
ANALYST-DOWNGRADE

TMO

THERMO FISHER SCIENTIFIC INC.
BEARISH
Impact 3/10
Horizonmonths Processed5mo ago SECanalyst-TMO-hsbc-20260603
HSBC double downgrade: Buy → Hold
Actionable Insight ▼ Bearish

HSBC's double-downgrade is a contrarian signal from a mediocre-accuracy firm, but the large PT cut and bearish short interest suggest near-term downside risk. Traders should watch for further downgrades or EPS misses before the July 21 earnings date; the bullish consensus may be vulnerable to a negative surprise.

DirectionBearish
Confidencemedium
Horizonmonths

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$473.57
T+0 close · Jun 3, 2026 · via day close
Latest settled
+33.16%
T+60 · $630.62
Vs SPY
+30.93%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 3 $473.57entry
  2. T+1 · 6mo ago +1.73%α +1.33% · $481.76
  3. T+5 · 5mo ago +1.79%α +5.61% · $482.04
  4. T+20 · 5mo ago +8.40%α +9.52% · $513.33
  5. T+60 · 3mo ago +33.16%α +30.93% · $630.62
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

HSBC double-downgraded Thermo Fisher Scientific (TMO) from Buy to Hold on June 3, slashing its price target by 19.4% to $540 from $670. The call is a sharp contrarian move against a consensus that remains 85% Buy-rated (29 of 34 analysts at Buy or Strong Buy). TMO currently trades at $482.08, implying a 13.4% upside to the new HSBC target but a 12% discount to the consensus mean of $611.56. HSBC's accuracy on TMO is 67% (2 of 3 calls) with a negative average return of -0.4%, ranking it below top-tier firms like Baird (83% on 6 calls) and Barclays (80% on 10 calls). The downgrade is the only negative analyst action in the past 30 days, with zero upgrades and one downgrade. EPS revisions are mixed: the current quarter saw 12 downward revisions in 30 days, while the next quarter (+1q) saw 14 upward revisions, suggesting near-term headwinds but a potential rebound. Insider selling is present but not alarming, two sales totaling ~$1M in March-April, with no buys. Institutional buying is strong, with FMR LLC adding 29% and Bank of America adding 34.9%. The bottom line: HSBC's downgrade is a minority view from a mediocre-accuracy firm, but the large PT cut and the double-downgrade signal warrant caution against the overwhelmingly bullish consensus.

Impact Score

Base Score
2/7
LLM Adjustment
+1
Final Score
3/10

Consensus & Targets

Buy / Strong Buy
29 (85%)
Hold
5
Sell / Strong Sell
0
Total Analysts
25
Mean PT
$611.56
Median PT
$615.00
High PT
$750.00
Low PT
$490.00
Current Price
$482.08
Implied Upside
+26.9%

Consensus is heavily bullish: 11 Strong Buy, 18 Buy, 5 Hold, 0 Sell, 0 Strong Sell, 85% Buy/Strong Buy (29 of 34 analysts). HSBC's Hold is a clear outlier against this consensus direction.

Mean PT is $611.56, median $615, high $750, low $490. Current price $482.08 implies 26.9% upside to the mean. HSBC's $540 target is 12% below the mean and just above the low end, making it one of the most bearish on the Street.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-06-03HSBCdowngradeHold$540.00
2026-05-08Wells FargomaintainOverweight$615.00
2026-04-24StifelmaintainBuy$600.00
2026-04-24BairdmaintainOutperform$639.00
2026-04-14BarclaysmaintainOverweight$625.00
2026-04-06Evercore ISI GroupmaintainOutperform$575.00
2026-01-30CitigroupmaintainBuy$685.00
2026-01-30TD CowenmaintainBuy$683.00
2026-01-30BarclaysmaintainOverweight$650.00
2026-01-09StifelmaintainBuy$700.00

30-day analyst activity: 0 upgrades, 1 downgrade (HSBC). EPS revisions show near-term caution: current quarter had 12 downward revisions vs 2 upward in 30 days, but next quarter (+1q) had 14 upward vs 3 downward, suggesting a potential inflection. Full-year 2026 estimates are stable (2 up, 0 down in 30 days).

Firm Track Record: HSBC

HSBC accuracy: 55% on 263 calls | avg return: 5.5%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Argus Research100%2/29.5%top tier
Baird83%5/610.5%top tier
Barclays80%8/108.5%top tier
Evercore ISI Group71%5/77%top tier
JP Morgan67%2/31.8%top tier
HSBC67%2/3-0.4%top tier
UBS60%3/57.9%above average
Wells Fargo50%4/8-2.4%below average
Stifel50%2/4-1.6%below average
RBC Capital50%2/4-1.6%below average

HSBC has a 67% accuracy rate on 3 TMO calls with a negative average return of -0.4%, placing it in the 'top tier' vs. average but below top performers like Baird (83% on 6 calls, +10.5% avg return) and Barclays (80% on 10 calls, +8.5% avg return). The best firm on TMO is Argus Research (100% on 2 calls, +9.5% avg return); the worst is Morgan Stanley (20% on 5 calls, -13.7% avg return).

Earnings Estimates

Next earnings: Jul 21, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$5.72$5.70 to $5.75$11.7B↑0 ↓0
0y$24.86$24.63 to $25.05$47.8B↑1 ↓0
+1y$27.30$26.25 to $29.07$50.4B↑1 ↓0
+1q$6.35$6.09 to $6.47$12.0B↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 2 sells
Congressional
Dwight Evans (democrat): sell $1,001 - $15,000
Congressional
Ro Khanna (democrat): buy $15,001 - $50,000
Congressional
Ro Khanna (democrat): buy $1,001 - $15,000
Institutional
FMR LLC: add (29%)
Institutional
NORGES BANK: new
Institutional
TWO SIGMA INVESTMENTS, LP: add (32.2%)
Short Interest
Short: 893,621 | Exempt: 848 | TRF Vol: 1,442,201 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)

Insider trades: two sells totaling ~$1M (Pettiti $185K, Shafer $803K) in March-April 2026, no buys. Congressional activity: one sell (Dwight Evans, $1K-$15K) and two buys (Ro Khanna, $16K-$65K combined), mixed. Institutional changes: strongly positive, FMR LLC added 29% ($5.7B), Norges Bank new position ($3.1B), Bank of America added 34.9% ($2.6B). Short interest is elevated at 62% short ratio (893,621 shares short vs 1.44M TRF volume), indicating bearish positioning. The analyst downgrade aligns with short interest and insider selling but diverges from institutional buying.

Investment Themes

Industrials & Manufacturing

Documents Analyzed

Report based on filing metadata.

Track record

21 reports on TMO

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.04% at T+60 after the Jun 11, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $700.22 Now $691.33 −1.27% settles Feb 11
  2. Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $676.94 Now $691.33 +2.13% settles Feb 3
  3. Oct 30, 202617d ago 8-K Neutral 2/10 Entry $682.65 Now $691.33 +1.27% settles Jan 29
  4. Oct 28, 202619d ago 144 Neutral 2/10 Entry $709.18 Now $691.33 −2.52% settles Jan 27
  5. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $694.02 Now $691.33 −0.39% settles Jan 19
  6. Oct 16, 20264w ago Institutional Cluster Neutral 3/10 Entry $690.00 Now $691.33 +0.19% settles Jan 13
  7. Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $608.54 Now $691.33 +13.60% settles Nov 27
  8. Aug 26, 202611w ago Insider Cluster Neutral 2/10 Entry $630.70 Now $691.33 +9.61% settles Nov 20
  9. Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $628.15 Now $691.33 +10.06% settles Nov 18
  10. Aug 18, 202613w ago Court Ruling Neutral 1/10 Entry $613.07 to $717.71 Now $691.33 +12.77% ▲ +17.07% +17.89% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026